Document is current
Any future updates will be listed below
-
Authors
Chaikovsky, Andrea C. https://orcid.org/0000-0003-1842-5384
Li, Chuan
Jeng, Edwin E.
Loebell, Samuel
Lee, Myung Chang https://orcid.org/0000-0002-7051-5822
Murray, Christopher W.
Cheng, Ran https://orcid.org/0000-0002-7617-3018
Demeter, Janos https://orcid.org/0000-0002-7301-8055
Swaney, Danielle L.
Chen, Si-Han https://orcid.org/0000-0002-2890-9764
Newton, Billy W.
Johnson, Jeffrey R.
Drainas, Alexandros P.
Shue, Yan Ting
Seoane, Jose A. https://orcid.org/0000-0002-3856-9177
Srinivasan, Preethi
He, Andy
Yoshida, Akihiro
Hipkins, Susan Q.
McCrea, Edel
Poltorack, Carson D.
Krogan, Nevan J. https://orcid.org/0000-0003-4902-337X
Diehl, J. Alan https://orcid.org/0000-0001-9854-5049
Kong, Christina
Jackson, Peter K.
Curtis, Christina https://orcid.org/0000-0003-0166-3802
Petrov, Dmitri A.
Bassik, Michael C. https://orcid.org/0000-0001-5185-8427
Winslow, Monte M. https://orcid.org/0000-0002-5730-9573
Sage, Julien https://orcid.org/0000-0002-8928-9968
- License Information
-
More Information
Article History
Received: 6 March 2020
Accepted: 18 March 2021
First Online: 14 April 2021
Competing interests
: J.S. has received research funding from Stemcentrx/Abbvie, Pfizer and Revolution Medicines. M.M.W. and D.P. have equity in, and are advisors for, D2GOncology. C.C. is a scientific advisor to GRAIL and reports stock options as well as consulting for GRAIL and Genentech. N.J.K. has received research support from Vir Biotechnology and F. Hoffmann-La Roche. The authors declare no other competing interests.
